These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20547640)

  • 41. Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh.
    Reddy S; Taori S; Poxton IR
    Clin Microbiol Infect; 2010 Apr; 16(4):340-6. PubMed ID: 20222891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal microbiota transplantation for recurrent clostridium difficile infection.
    Brandt LJ; Reddy SS
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S159-67. PubMed ID: 21992957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative therapies for Clostridium difficile infections.
    Venuto C; Butler M; Ashley ED; Brown J
    Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stool transplantation for older patients with Clostridium difficile infection.
    Rubin TA; Gessert CE; Aas J
    J Am Geriatr Soc; 2009 Dec; 57(12):2386. PubMed ID: 20122011
    [No Abstract]   [Full Text] [Related]  

  • 45. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent Clostridium difficile infection: causality and therapeutic approaches.
    Johnson S
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S33-6. PubMed ID: 19303567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile infection: current perspectives.
    Janka J; O'Grady NP
    Curr Opin Crit Care; 2009 Apr; 15(2):149-53. PubMed ID: 19578325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.
    O'Connor JR; Johnson S; Gerding DN
    Gastroenterology; 2009 May; 136(6):1913-24. PubMed ID: 19457419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC; Griesbach CL; DiBaise JK; Orenstein R
    Mayo Clin Proc; 2013 Aug; 88(8):799-805. PubMed ID: 23910407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies.
    To KB; Napolitano LM
    Surg Infect (Larchmt); 2014 Oct; 15(5):490-502. PubMed ID: 25314344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.
    Rubin TA; Gessert CE; Aas J; Bakken JS
    Anaerobe; 2013 Feb; 19():22-6. PubMed ID: 23182843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of first recurrence of Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C. difficile infection (CDI) in a long-term acute care facility (LTAC).
    Goldstein EJ; Polonsky J; Touzani M; Citron DM
    Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea.
    Surawicz CM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S64-70. PubMed ID: 18545161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of Clostridium difficile infection in pediatric patients.
    Esposito S; Umbrello G; Castellazzi L; Principi N
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):747-55. PubMed ID: 25912469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.